Etiqueta de registo: 00737cam 02200229 04500
001 965640
003 http://id.bnportugal.gov.pt/bib/porbase/965640
005 19990823155400.0
035 ## $a(bn)965640
095 ## $aPTBN01046434
100 ## $a19990311d1998 k y0pory0103 ba
101 0# $aeng
102 ## $aPT
105 ## $ay z 001yy
106 ## $ar
200 1# $aNimesulide$e?a ?multifactorial therapeutical approach to the inflammatory process?$eclinical experience$eabstracts$f[ed. Helsinn]
210 #9 $a[Lisboa$cHelsinn,$dD.L. 1998]
215 ## $a139 p.$d30 cm
675 ## $a615.27$vBN$zpor$3291285
712 02 $aHelsinn Produtos Farmacêuticos$4340$366509
801 #0 $aPT$bBN$gRPC
966 ## $lABMAD$mABMAD$s0013598FGA6LIV
966 ## $c2$lBN$mFGMON$sS.A. 89132 V.$x1
966 ## $c2$lBN$mFGMON$sS.A. 89132 V.$x1
966 ## $lBPMP$mBPMP$sL4-10-126 $x1
966 ## $b003$lUCBG$mUCBG$s6-35-3-19 $x1

Etiqueta de registo: 00908cas 2200313 450
001 864323
003 http://id.bnportugal.gov.pt/bib/porbase/864323
005 20010510142400.0
011 ## $a0873-5603
021 ## $aPT$b77781/94
035 ## $a(bn)864323
095 ## $aPTBN00619957
100 ## $a19940825a19949999k y0pory0103 ba
101 0# $apor
102 ## $aPT
106 ## $ar
110 ## $aahazz..0yy0
200 1# $aOxigénio$erevista médica$fed. e propr. Helsinn Produtos Farmacêuticos$gdir. Edmundo Martinho
207 #0 $aN. 1 (Maio 1994)-
210 #9 $aLisboa$cH.P.F.,$d1994-
215 ## $d30 cm
326 ## $aTrimestral
530 1# $aOxigénio (Algés)
606 ## $aMedicina$x[Periódicos]$2SIPOR$3146676
620 ## $dLisboa
675 ## $a61(05)$vBN$zpor$3288508
702 #1 $aMartinho,$bEdmundo,$f1955-$4300$32138384
712 02 $aHelsinn Produtos Farmacêuticos$4650$366509
801 #0 $aPT$bBN$gRPC
966 ## $c2$dN. 1$lBN$mFGREV$sP.P. 21898 V.$x1
966 ## $lBPMP$mBPMP$sP-B-8594
966 ## $lUCBG$mUCBG$sA-23-44-2

Etiqueta de registo: 00859cas 02200289 04500
001 588818
003 http://id.bnportugal.gov.pt/bib/porbase/588818
005 20001021112200.0
021 ## $aPT$b90762/95
035 ## $a(bn)588818
095 ## $aPTBN00798114
100 ## $a19960530b1995 m y0pory0103 ba
101 0# $apor
102 ## $aPT
106 ## $ar
110 ## $aahazz..0yy0
200 1# $aCheck-up$fpropr. e ed. Helsinn Produtos Farmacêuticos$gdir. Edmundo Martinho
210 #9 $aAlgés$cH.P.F.,$d[1995]
215 ## $d24 cm
303 ## $aDescrição baseada em: n. 2 (Maio 1995)
326 ## $aTrimestral
620 ## $dAlgés
675 ## $a615(05)$vBN$zpor$3288352
702 #1 $aMartinho,$bEdmundo,$f1955-$4300$32138384
712 02 $aHelsinn Produtos Farmacêuticos$4650$366509
801 #0 $aPT$bBN$gRPC
930 ## $lBN$mBG$dP.P. 22733 V.$jN. 2 (Maio 1995)-
966 ## $c2$lBN$mFGREV$sP.P. 22733 V.$x1
966 ## $lBPMP$mBPMP$sP-A-4951

Etiqueta de registo: 01105cam 22003373 450
001 637804
003 http://id.bnportugal.gov.pt/bib/porbase/637804
005 19990105000000.0
035 ## $a(bn)637804
095 ## $aPTBN00849435
100 ## $a19970109d1993 m y0pory0103 ba
101 0# $apor$deng
102 ## $aPT
105 ## $ay z 000yy
106 ## $ar
200 1# $aFisiologia da fadiga$fRui Pedro Miller.$c?A ?fadiga muscular em treino desportivo$edelimitação conceptual e controlo do treino$fJosé Gomes Pereira$g[ed. lit.] Helsinn
210 #9 $a[Lisboa]$cCentro de Investigação Médico Desportivo,$d1993 [D.L. 1996]
215 ## $a25 p.$d28 cm
225 2# $aMedicina desportiva em revista
320 ## $aContém bibliografia
606 ## $2SIPOR$368295
675 ## $a612$vBN$zpor$3288075
675 ## $a613.8$vBN$zpor$3291263
675 ## $a159.94$vBN$zpor$3290029
675 ## $a796-057$vBN$zpor$3335832
700 #1 $aMiller,$bRui$385554
701 #1 $aPereira,$bJosé Gomes$3240265
712 02 $aHelsinn Produtos Farmacêuticos$4340$366509
801 #0 $aPT$bBN$gRPC
966 ## $c2$lBN$mFGMON$sS.A. 83038 V.$x1
966 ## $c2$lBN$mFGMON$sS.A. 83038 V.$x1
997 ## $aBIBEOD

Etiqueta de registo: 00722cas 02200265 04500
001 259628
003 http://id.bnportugal.gov.pt/bib/porbase/259628
005 19981205221700.0
035 ## $a(bn)259628
095 ## $aPTBN00270134
100 ## $a19910402d1991 k y0pory0103 ba
101 0# $apor
102 ## $aPT
106 ## $ae
110 ## $acuuzz..0yy0
200 1# $aColominte$fHelsinn
207 #0 $aN. 1-
210 #9 $a[Lisboa]$cHelsinn,$d[D.L. 1991]-
215 ## $d42 cm
606 ## $aFarmacologia$2BN-P$2SIPOR$3151405
620 ## $dLisboa
675 ## $a616.348(469)(05)$vBN$zpor$3439669
712 02 $aHelsinn Produtos Farmacêuticos$4650$366509
801 #0 $aPT$bBN$gRPC
966 ## $c2$dN. 1$lBN$mFGJOR$sJ. 4975 V.$x1
966 ## $c2$dN. 1$lBN$mFGJOR$sJ. 4975 V.$x1
966 ## $lBPMP$mBPMP$sP-C-2188
966 ## $lUCBG$mUCBG$s8-13-22-M 1

Etiqueta de registo: 00894ckm 02200253 04500
001 198517
003 http://id.bnportugal.gov.pt/bib/porbase/198517
005 19981130033600.0
035 ## $a(bn)198517
095 ## $aPTBN00206066
100 ## $a19891211d1989 am y0pory010305 ba
101 0# $apor
102 ## $aPT
200 1# $a?O ?que há 2 anos prometemos$bVisual gráfico]$fHelsinn Produtos Farmacêuticos
210 #9 $aLisboa$cH.,$d[D.L.1989]
215 ## $a1 cartaz$ccolor.$d41x61 cm
330 ## $aRep. fot. de várias embalagens de produtos e publicações lançados pelo referido laboratório
675 ## $a615.1(084.5)$vBN$zpor$3396512
675 ## $a766(=1:469)"198"(084.5)$vBN$zpor$31302430
710 02 $aHelsinn Produtos Farmacêuticos$366509
801 #0 $aPT$bBN$gRPC
856 40 $uhttps://purl.pt/15785
856 41 $uhttps://purl.pt/15785/service/media/cover/low
958 ## $aBND$bInterno$cDigitalizado
966 ## $lBN$mICONOG$sCT. 5952 A.$x1

Etiqueta de registo: 00906ckm 02200277 04500
001 196279
003 http://id.bnportugal.gov.pt/bib/porbase/196279
005 20010911192000.0
035 ## $a(bn)196279
095 ## $aPTBN00203637
100 ## $a19880601d1988 am y0pora010305 ba
101 0# $apor
102 ## $aPT
200 1# $aStagid$bVisual gráfico]$eestabilizar a glicémia sem risco de hipoglicémia$fHelsinn
210 #9 $a[S.l.]$cH.,$d1988
215 ## $a1 cartaz$ccolor.$d69x48 cm
330 ## $aEsquema gráfico do tratamento
675 ## $a615.25(084.5)$vBN$zpor$3310822
675 ## $a616.379-008.6(084.5)$vBN$zpor$3302371
675 ## $a766(=1:469)"198"(084.5)$vBN$zpor$31302430
710 02 $aHelsinn Produtos Farmacêuticos$366509
801 #0 $aPT$bBN$gRPC
856 40 $uhttps://purl.pt/11288
856 41 $uhttps://purl.pt/11288/service/media/cover/low
958 ## $aBND$bInterno$cDigitalizado
966 ## $lBN$mICONOG$sCT. 5320 A.
998 ## $aBN8819 - 00285

Etiqueta de registo: 00627cas 2200217 450
001 123665
003 http://id.bnportugal.gov.pt/bib/porbase/123665
005 19981121074000.0
035 ## $a(bn)123665
095 ## $aPTBN00129226
100 ## $a19880502a19889999m y0pora0103 ba
101 0# $apor
102 ## $aPT
200 1# $aHelsinn informação$fHelsinn Produtos Farmacêuticos
207 #0 $aNº1 (Jan. 1988)-
210 #9 $aLisboa$cH.P.F.,$d1988-
215 ## $d30 cm
606 ## $aFarmacologia$2BN-P$2SIPOR$3151405
675 ## $a615.1(05)$vBN$zpor$3298595
712 02 $aHelsinn Produtos Farmacêuticos$4650$366509
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGREV$sP.P. 18673 V.
966 ## $lBPMP$mBPMP$sP-B-5645
966 ## $lUCBG$mUCBG$s10-7 A-19-129

Etiqueta de registo: 00608cas 2200217 450
001 123713
003 http://id.bnportugal.gov.pt/bib/porbase/123713
005 19990823155300.0
035 ## $a(bn)123713
095 ## $aPTBN00129274
100 ## $a19880624a19889999k y0pora0103 ba
101 0# $apor$aeng
102 ## $aPT
200 1# $aDiabetes$erevista das revistas$fHelsinn
207 ## $aNº1 (Jun. 1988)-
210 #9 $aLisboa$cH.,$d1988-
215 ## $d30 cm
606 ## $aMedicina$2BN-P$322364
675 ## $a616.379(05)$vBN$zpor$3342434
712 02 $aHelsinn Produtos Farmacêuticos$4650$366509
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGREV$sP.P. 18746 V.
966 ## $lBPMP$mBPMP$sP-B-5705
966 ## $lINP$mINP$sP.S. 0028
966 ## $lUCBG$mUCBG$sA-27-28

Etiqueta de registo: 00745cas 02200265 04500
001 120011
003 http://id.bnportugal.gov.pt/bib/porbase/120011
005 19981121020000.0
035 ## $a(bn)120011
095 ## $aPTBN00125475
100 ## $a19890510d1989 m y0pora0103 ba
101 0# $apor
102 ## $aPT
106 ## $ar
110 ## $aauazz..0uu0
200 1# $aInflamação$erevista das revistas$fHelsinn Produtos Farmcêuticos
207 #0 $a1-
210 ## $aLisboa$cH.P.F.,$d[D.L. 1989]-
215 ## $d30 cm
606 ## $aMedicina$2BN-P$322364
620 ## $dLisboa
675 ## $a616-002(05)$vBN$zpor$3338447
712 02 $aHelsinn Produtos Farmacêuticos$4650$366509
801 #0 $aPT$bBN$gRPC
966 ## $c2$d1$lBN$mFGREV$sP.P. 19159 V.$x1
966 ## $c2$d1$lBN$mFGREV$sP.P. 19159 V.$x1
966 ## $lBPMP$mBPMP$sP-B-5705(A)
966 ## $lUCBG$mUCBG$sA-21-49

Etiqueta de registo: 00717cas 2200265 450
001 728212
003 http://id.bnportugal.gov.pt/bib/porbase/728212
005 19990108000000.0
035 ## $a(bn)728212
095 ## $aPTBN00515420
100 ## $a19931213a19939999k y0pory0103 ba
101 0# $apor
102 ## $aPT
106 ## $ar
110 ## $aauuzz..0zz0
200 1# $aForum vet$fHelsinn
207 #0 $aN. 1 (Maio 1993)-
210 #9 $aSintra$cH.,$d1993-
215 ## $d30 cm
606 ## $aFarmacologia$2BN-P$2SIPOR$3151405
620 ## $dSintra
675 ## $a619(05)$vBN$zpor$3301994
712 02 $aHelsinn Produtos Farmacêuticos$4650$366509
801 #0 $aPT$bBN$gRPC
966 ## $c2$dN. 1$lBN$mFGREV$sP.P. 21388 V.$x1
966 ## $c2$dN. 1$lBN$mFGREV$sP.P. 21388 V.$x1
966 ## $lBPMP$mBPMP$sP-B-8183
966 ## $lUCBG$mUCBG$sA-12 B-14-2

Etiqueta de registo: 00573cam 22001931 450
001 1951232
003 http://id.bnportugal.gov.pt/bib/porbase/1951232
005 20030507132400.0
010 ## $a0-631-14365-3$benc.$d7.500$00
035 ## $311634
095 ## $aPTBN00326952
100 ## $a19000001d1986 k y0pora0103 ba
101 0# $aeng
102 ## $aGB
200 1# $aStates in history$fedited by John A. Hall
210 ## $aOxford$cBasil Blackwell,$d1986
215 ## $aVI, 317 p.
675 ## $a371.26(469)"2001/2003"(047.3)$vBN$zpor$3288285
702 #1 $aHall,$bJohn Ainger$4340$3189491
801 #0 $aPT$bBN$gRPC
977 ## $1P.-1383$2coop$4ULICS$6mq477887$7bc$8coop$9ULICS$b14.474$k0